These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 33778713)
1. Texture Analysis of Apparent Diffusion Coefficient Maps in Cervical Carcinoma: Correlation with Histopathologic Findings and Prognosis. Yamada I; Oshima N; Miyasaka N; Wakana K; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Kobayashi D Radiol Imaging Cancer; 2020 May; 2(3):e190085. PubMed ID: 33778713 [TBL] [Abstract][Full Text] [Related]
2. Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and Prognosis. Yamada I; Miyasaka N; Kobayashi D; Wakana K; Oshima N; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Eishi Y Radiol Imaging Cancer; 2019 Nov; 1(2):e190054. PubMed ID: 33778684 [TBL] [Abstract][Full Text] [Related]
3. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation. Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349 [TBL] [Abstract][Full Text] [Related]
4. The Value of Diffusion-Weighted Imaging in Predicting the Prognosis of Stage IB-IIA Cervical Squamous Cell Carcinoma After Radical Hysterectomy. Zhou G; Chen X; Tang F; Zhou J; Wang Y; Wang Z Int J Gynecol Cancer; 2016 Feb; 26(2):361-6. PubMed ID: 26807567 [TBL] [Abstract][Full Text] [Related]
5. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy. Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244 [TBL] [Abstract][Full Text] [Related]
6. Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps. Yin JD; Song LR; Lu HC; Zheng X World J Gastroenterol; 2020 May; 26(17):2082-2096. PubMed ID: 32536776 [TBL] [Abstract][Full Text] [Related]
7. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images. Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314 [TBL] [Abstract][Full Text] [Related]
8. Value of whole-lesion apparent diffusion coefficient (ADC) first-order statistics and texture features in clinical staging of cervical cancers. Guan Y; Li W; Jiang Z; Zhang B; Chen Y; Huang X; Zhang J; Liu S; He J; Zhou Z; Ge Y Clin Radiol; 2017 Nov; 72(11):951-958. PubMed ID: 28728757 [TBL] [Abstract][Full Text] [Related]
9. Diffusion Kurtosis Imaging in the Assessment of Cervical Carcinoma. Wang M; Perucho JAU; Chan Q; Sun J; Ip P; Tse KY; Lee EYP Acad Radiol; 2020 May; 27(5):e94-e101. PubMed ID: 31324577 [TBL] [Abstract][Full Text] [Related]
10. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study]. Wang W; Shang C; Huang J; Chen S; Shen H; Yao S Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872 [TBL] [Abstract][Full Text] [Related]
11. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation. Liu Y; Zhang Y; Cheng R; Liu S; Qu F; Yin X; Wang Q; Xiao B; Ye Z J Magn Reson Imaging; 2019 Jan; 49(1):280-290. PubMed ID: 29761595 [TBL] [Abstract][Full Text] [Related]
12. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients. Heo SH; Shin SS; Kim JW; Lim HS; Jeong YY; Kang WD; Kim SM; Kang HK Korean J Radiol; 2013; 14(4):616-25. PubMed ID: 23901319 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of various apparent diffusion coefficient measurement techniques in pre-operative staging of early cervical carcinoma. Mongula JE; Bakers F; Slangen BFM; van Kuijk SMJ; Kruitwagen RFPM; Mihl C Eur J Radiol; 2019 Sep; 118():101-106. PubMed ID: 31439228 [TBL] [Abstract][Full Text] [Related]
14. Radiomics Analysis of Multiparametric MRI Evaluates the Pathological Features of Cervical Squamous Cell Carcinoma. Wu Q; Shi D; Dou S; Shi L; Liu M; Dong L; Chang X; Wang M J Magn Reson Imaging; 2019 Apr; 49(4):1141-1148. PubMed ID: 30230114 [TBL] [Abstract][Full Text] [Related]
15. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy. Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142 [TBL] [Abstract][Full Text] [Related]
17. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer. Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG J Magn Reson Imaging; 2017 Jun; 45(6):1771-1779. PubMed ID: 27859961 [TBL] [Abstract][Full Text] [Related]
18. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy. Onal C; Erbay G; Guler OC J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800 [TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging. Woo S; Kim SY; Cho JY; Kim SH Radiol Med; 2018 Mar; 123(3):209-216. PubMed ID: 29058233 [TBL] [Abstract][Full Text] [Related]
20. A Predictor of Tumor Recurrence in Patients With Endometrial Carcinoma After Complete Resection of the Tumor: The Role of Pretreatment Apparent Diffusion Coefficient. Kuwahara R; Kido A; Tanaka S; Abiko K; Nakao K; Himoto Y; Nishio N; Kurata Y; Mandai M; Togashi K Int J Gynecol Cancer; 2018 Jun; 28(5):861-868. PubMed ID: 29683878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]